Online ISSN: 2515-8260

Keywords : Autologous


THE EFFICACY OF AUTOLOGOUS PLATELET RICH PLASMA INJECTION IN CHRONIC PLANTAR FASCITIS, A PROSPECTIVE STUDY

Dr VADLAMUDI VINAY CHOWDARY, Dr KONDAREDDY HARI KRISHNA REDDY, Dr AITHAGANI SANDEEP KUMAR

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 34-42

INTRODUCTION
Plantar fascitis is one of the most common tendinopathy and cause of heel pain. It may get resolved with time and conservative treatment like stretching exercises and oral medications. Recent advance in treatment of chronic plantar fascitis is the use of local PRP injections. It has advantages like being autologous and rich in growth factors. The purpose of this study is to determine the effectiveness of local PRP injection in chronic plantar fascitis.
MATERIALS AND METHODS
This study was conducted from September 2020 to March 2022 in Narayana Medical College and Hospital, Nellore. 30 patients who came to op were selected based on inclusion and exclusion criteria. 3ml of autologous PRP was extracted and injected into heel area. Patients were followed up at 0,1,3,6 months intervals and at each follow up pain was evaluated using Numerical pain score.
 
RESULTS
Patients are followed up at 0,1,3,6 months. At each follow up patients Numerical pain score was calculated and mean was obtained for all patients. The mean pain was 8.5 pre-injection. The mean Numerical pain score at 0,1,3,6 month was 8.5, 4.25, 0.89, 0.33 respectively.
CONCLUSION
Intralesional autologous platelet rich plasma injections were safe and effective in treatment of chronic plantar fasciitis with maximum effect observed after 3rd month and sustaining till 6th month

The treatment of benign lesions of the proximal femur with nonvascularised autologous fibular strut grafts

Dr. Shailesh Kumar, Dr. Sanjeev Kumar Rakesh, Dr. Gangdayal Sharma, Dr. Kumar Nitesh

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 5848-5854

Introduction: The relative use of the non-vascularised fibula grafts was recommended
as the gold standard for the biological reconstructions has been in practice for more
than 60 years. The aim and objective of this retrospective study was primarily focussed
to analyse the results with regard to variables such as consolidation, hypertrophy at the
graft-host junctions and presence of certain complications as well as to assess the
functional and oncological outcomes.
Materials and Methodology: Fifteen patients reported with primary benign tumours
involving the proximal femur includes the femoral neck were treated surgically at the
department of orthopaedics, IGIMS Patna between October 2019 and March 2021.
There were ten males and five females. Their average age at the time of presentation
was 34 years (21–68) and the average follow-up time was considered up to 12 months.
Results: Intraoperative blood transfusion was required in eight patients (53%;
autologous blood transfusion in five, blood component transfusion in three).There was
no significant difference in the duration of restriction of full weight-bearing between the
patients who were treated with CPC and CHA (p = 0.52, Mann-Whitney U test). All
patients had equally regained full physical function without the development of pain in
the final follow-up period.
Conclusion: To conclude, it has been suggested that the management of the bone lesions
involving the proximal femur with the use of compression hip screw and synthetic bone
graft is considered as relatively safe and effective method.